针对头部和部状细胞癌的CAR-T细胞疗法的进展和挑战
Sahand Saeidpour Masouleh1, Kamyar Nasiri2, Ava Ostovar Ravari3
1Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Biomarker research
|May 1, 2025
概括
化学抗原受体 (CAR) T细胞疗法对头部和部状细胞癌 (HNSCC) 显示出希望. 研究探索了新的目标和策略,以克服治疗这种侵袭性癌症的挑战.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 头部和部状细胞癌 (HNSCC) 是一种具有恶性恶性瘤,结果不佳,特别是在复发/转移的情况下.
- 目前的治疗方法,如手术,放射,化疗和免疫检查点抑制剂,由于瘤异质性,免疫逃避和耐药性而表现出局限性.
- 化学抗原受体 (CAR) T细胞疗法已经改变了血液癌症的治疗方法,但在像HNSCC这样的固体瘤中面临障碍.
研究的目的:
- 审查CAR T细胞治疗HNSCC的现状.
- 确定潜在的CAR T细胞点,并讨论实体瘤应用中的挑战.
- 探索HNSCC中CAR T细胞的创新策略和未来治疗潜力.
主要方法:
- 在HNSCC中对CAR T细胞治疗机制,目标和策略的文献综述.
- 分析挑战,包括瘤微环境 (TME) 免疫抑制和抗原异质性.
- 检查新兴的方法,如双重准,装甲CAR和组合疗法.
主要成果:
- 一些与瘤相关的抗原 (TAA),如EGFR,HER2,B7-H3,CD44v6,CD70,CD98和MUC1被确定为HNSCC中潜在的CAR T细胞标.
- 正在开发诸如双重定位CAR,装甲CAR和CRISPR修改等创新策略,以提高有效性.
- 结合免疫检查点抑制剂和抗TGF-β抗性CAR设计的组合疗法显示出改善结果的希望.
结论:
- 尽管存在挑战,CAR T细胞疗法在治疗HNSCC方面具有显著的潜力.
- 克服TME诱导的免疫抑制和抗原异质性对于成功的翻译至关重要.
- 对新的点,先进的CAR设计和组合策略的进一步研究对于实现HNSCC的全部治疗潜力至关重要.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
376
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
589
相关概念视频
01:27Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:30Cancer Vaccines
237
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
237
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K